You searched for - OHE

European Union flag on the background of old locked doors

Insight
May 2023

New Drugs to Tackle Antimicrobial Resistance: Breaking the European Deadlock: Part 1 – Defining Objectives

A Novel Incentive Model for Uptake of Diagnostics to Combat Antimicrobial Resistance

Read more

Incentivising New Antibiotics: Designing a Value-Based Delinked Pull Incentive Mechanism

Read more

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

Read more

© photoguns

G7Antibiotics_blog_featuredimage

Insight
December 2022

G7 Investments in New Antibiotics Would Pay Off – For Everyone

Insight
November 2022

The World Needs New Antibiotics. A Proposed US Program to Develop Them Offers a High Pay-Off

Blog 4

Insight
October 2022

The Economics of Antibiotics – Part 4: What Does the Antibiotics Market of the Future Look Like?

Insight
October 2022

The Economics of Antibiotics – Part 3: Creating a Healthy Global Market for New Antibiotics

Insight
October 2022

The Economics of Antibiotics – Part 2: Value Assessment within the NICE-NHS AMR Pilot

Insight
October 2022

The Economics of Antibiotics – Part 1: Why NICE and NHS England are Testing an Innovative HTA and Payment Model to Tackle Antimicrobial Resistance

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

Read more

© NCI/Unsplash

Insight
May 2021

Would Waiving COVID-19 Vaccines Patents Save Lives?

It Takes Two to Tango: When do Conditional Reimbursement Risk-Sharing Schemes Work for Both Parties?

Read more

Working Towards a Sustainable, Healthy Market for Vaccines: a Comprehensive Framework to Support Policy Dialogue and Decision-Making

Read more

Key Considerations for Early Access Schemes for Single-Administration (One-Time) Therapies

Read more

Exploring the Financial Sustainability of Gene Therapies

Read more

© Sergey Nivens